EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease

Marina Peball, Dora Valent, Anna Grossauer, Kathrin Marini, Philipp Ellmerer, Jonas Wallnöfer, Florian Krismer, Atbin Djamshidian, Klaus Seppi, Beatrice Heim

Journal of Parkinson’s Disease · 2023

DOI: 10.3233/jpd-225108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Marina Peball und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Sarcopenia, Parkinson Disease, Frailty. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is characterized by a progressive loss of muscle mass, strength, and function resulting in adverse health outcomes. Current assessment strategies are bothersome and means to simplify the diagnosis are an unmet medical need in Parkinson’s disease (PD).

Objective

To evaluate temporal muscle thickness (TMT) obtained on routine cranial MRI as a surrogate marker of sarcopenia in PD patients.

Methods

We correlated TMT from axial non-contrast-enhanced T1-weighted sequences of MRI close (±12 months) to an outpatient visit including sarcopenia (EWGSOP1, EWGSOP2, SARC-F), frailty (Fried’s criteria, clinical frailty scale), and disease characteristics of Parkinson’s patients (Hoehn and Yahr-scale, Movement Disorder Society-Unified Parkinson’s Disease Rating Scale, quality of life with the Parkinson’s Disease Questionnaire-8) assessments.

Results

Cranial MRI was available in 32 patients with a mean age of 73.56±5.14 years, mean disease duration of 11.46±5.66 years, and median Hoehn and Yahr stage of 2.5. The mean TMT was 7.49±2.76 (7.15) mm. Mean TMT was significantly associated with sarcopenia (EWGSOP2, p = 0.018; EWGSOP1, p = 0.023) and frailty status (physical phenotype; p = 0.045). Moreover, there were significant moderate to strong correlations between TMT measurement and appendicular skeletal muscle mass index ( r: 0.437, p = 0.012), as well as handgrip strength ( r: 0.561, p < 0.001).

Conclusion

Reduced TMT seems to be a promising surrogate marker for sarcopenia (EWGSOP2) and muscle strength in this pilot study in PD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaParkinson DiseaseFrailtyHumansHand StrengthQuality of LifePilot ProjectsTemporal Muscle

Stichwörter der Autor:innen

Parkinson’s diseaseTemporal muscle thicknessbiomarkerfrailtysarcopenia

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Zitieren

APA

Peball, M., Valent, D., Grossauer, A., Marini, K., Ellmerer, P., Wallnöfer, J., Krismer, F., Djamshidian, A., Seppi, K., & Heim, B. (2023). Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-225108

Vancouver

Peball M, Valent D, Grossauer A, Marini K, Ellmerer P, Wallnöfer J, et al. Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-225108

BibTeX
@article{Peball2023,
  author = {Peball, Marina and Valent, Dora and Grossauer, Anna and Marini, Kathrin and Ellmerer, Philipp and Wallnöfer, Jonas and Krismer, Florian and Djamshidian, Atbin and Seppi, Klaus and Heim, Beatrice},
  title = {Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  doi = {10.3233/jpd-225108}
}
Kostenlos starten →